Several modestly sized retrospective studies (n = 15 to n = 46) of BRAF-mutated NSCLC patients treated with ICIs demonstrate ORR comparable to those seen in landmark clinical trials [97,98,99,100]. Here, BRAF is linked to non-small cell lung carcinoma.